 |
Rakuten Aspyrian
Last updated: September 27, 2025
Miguel Garcia Guzman, Founder
China | Funding: $737.6M (+)
Website: https://rakutenaspyrian.com/
Rakuten Aspyrian is developing tumor-targeted precision therapies based on its proprietary platform Photoimmunotherapy.
Website: https://rakutenaspyrian.com/
Rakuten Aspyrian is developing tumor-targeted precision therapies based on its proprietary platform Photoimmunotherapy.
